Zydus Lifesciences Ltd on Tuesday released its fiscal fourth quarter earnings with profit at Rs 1170.90 crore, missing estimates. This was marginally lower than Rs 1182.30 crore recorded during the corresponding quarter of FY24. It posted revenue from operations at Rs 6527.90 crore, up 17.96 per cent as against Rs 5533.80 crore reported during the fourth quarter of previous financial year. The company EBITDA stood at Rs 2126 crore.
According to a CNBC TV18 poll, Zydus Lifesciences was expected to record Q4 profit at Rs 1379.6 crore and revenue for the quarter in review was estimated at Rs 6,321.5 crore.
ALSO READBharat Electronics projects Rs 27,000 crore orders in FY26; QRSAM could add Rs 30,000 crore more, says management
For the full year, revenue from operations stood at Rs 23,241.50 crore, up 19 per cent over last year. Net profit, adjusted for exceptional items, came in at Rs 4745.10 crore, up 23 per cent YoY. Research & Development (R&D) investments for the year stood at Rs 1855.50 crore (8.0 per cent of revenues). The company recorded capex (organic) for the full year at Rs 1214.00 crore.
Dr Sharvil Patel, Managing Director, Zydus Lifesciences, said, “We are happy to conclude FY 2025 on a strong note, with all our businesses surpassing our growth expectations. The commercial success of our extensive product portfolio combined with operating leverage has significantly bolstered profitability and financial health. We made meaningful progress in our differentiated pipeline and added new capabilities to ensure sustainable growth.”
Dividend announcement
The company board has recommended a final dividend of Rs 11 (@1100 per cent) per equity share of Re 1 each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 12, 2025.
It further announced the record date for the dividend payment as Friday, July 25, 2025, to determine the list of shareholders entitled to receive the final dividend for the Financial Year ended on March 31, 2025. “The company shall make the payment of dividend, subject to deduction of tax at source, on or around August 14, 2025, subject to the approval of the same by the shareholders at the AGM,” it said in a regulatory filing.
Q4 performance across regions and segments
India Geography comprises of formulations as well as consumer wellness businesses and accounted for 39 per cent of consolidated revenues.
» Read More
